SEARCH RESULT

Wednesday, February 22, 2023
Elanco adds animal health veteran to executive committee
Elanco Animal Health announced on February 20 the appointment of Tim Bettington as the company's executive vice president of corporate strategy and market development.
Monday, November 28, 2022
Elanco and Tonisity International form partnership focused on gut enhancing swine products
Elanco Animal Health Incorporated and Tonisity International Limited have entered into a distribution and promotion agreement in respect of Tonisity's novel, gut enhancing porcine products, Tonisity Px™ and Tonisity PxW™.
Wednesday, August 3, 2022
AgNext and Elanco announce strategic alliance to advance livestock sustainability
AgNext at Colorado State University (US) and Elanco Animal Health Incorporated have announced a strategic alliance as part of a continued commitment to pioneer sustainability solutions for animal agriculture, transforming the next frontier ...
Tuesday, May 10, 2022
Elanco & DSM announce alliance in US for Bovaer feed additive for cattle
Elanco Animal Health Incorporated and Royal DSM have created a strategic alliance connecting both companies to address the mitigation of climate change's impact by reducing greenhouse gas emissions from farming.
Wednesday, April 27, 2022
Elanco and DSM announce alliance in US for Bovaer® feed additive for cattle
Elanco Animal Health Incorporated and Royal DSM have created a strategic alliance connecting both companies to address the mitigation of climate change's impact by reducing greenhouse gas emissions from farming.
Tuesday, January 4, 2022
Cobb names former Elanco executive as president
Cobb-Vantress, a wholly owned subsidiary of Tyson Foods, has announced the appointment of Joyce J. Lee as its new president.
Tuesday, August 10, 2021
Elanco's farm-animal business hit by lower hog, poultry prices
Elanco Animal Health Inc. said on August 9 that its farm-animal business has been hit by lower prices for hogs and poultry abroad.
Wednesday, April 7, 2021
Stonehaven Incubate secures further investment from Elanco
Stonehaven Incubate has announced closing a further capital raising from securing significant investment from existing shareholder Elanco, and from Argenta, a leading animal health CRO (contract research organisation) and CMO (contract manu ...
Wednesday, March 3, 2021
Elanco introduces vaccine for bovine pneumonia and BRD
Elanco Animal Health Incorporated has introduced NUPLURA PH+, providing fast, smooth and flexible protection against bovine respiratory disease (BRD), Bovine Veterinarian reported.
Tuesday, August 4, 2020
Elanco Brazil appoints new director general after completing Bayer animal health acquisition
United States-based Elanco Animal Health's Brazil unit appointed Sérgio Schuler as director general after the company concluded its purchase of Bayer's animal health division on August 3, Reuters reported.
Sunday, July 26, 2020
US approves Elanco's Bayer Animal Health acquisition
The US Federal Trade Commission (FTC) has given unanimous approval to Elanco Animal Health Incorporated for its acquisition of Bayer Animal Health, a division of Bayer AG, Southeast AgNet reported.
Friday, July 17, 2020
Neogen plans to acquire US rightsto Elanco's cattle insecticide
NEOGEN Corporation announced July 16 that, in line with the US Federal Trade Commission (FTC) July 15 press release, it plans to acquire the US rights to Elanco's StandGuard® Pour-on for horn fly and lice control in beef cattle, and re ...
Wednesday, July 15, 2020
Elanco decides against Bayer's Canadian rights in deal, set to divest brands
Elanco Animal Health will divest two of its brands and forgo obtaining Bayer AG's Canadian distribution rights to poultry insecticides as it completes its US$7.6 billion deal to buy Bayer's veterinary drugs unit, Reuters reported.
Tuesday, June 9, 2020
Elanco announces target date for closing Bayer deal
Elanco Animal Health has announced that it will complete its acquisition of Bayer Animal Health on August 3, the company stated in a Monday release, Kansas City Business Journal reported.
Monday, January 6, 2020
Elanco to present at the 38th Annual J.P. Morgan Healthcare Conference
January 6, 2020 Elanco to present at the 38th Annual J.P. Morgan Healthcare Conference Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the 38th Annual J.P. Morgan Healthcare Conference on January 14, 2020, in San Francisc ...

Follow Us

FacebookTwitterLinkedIn